Osimertinib vs Rabeprazole
Osimertinib vs Rabeprazole: Overview
This comparison examines the pharmacological differences between Osimertinib and Rabeprazole.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.
Pharmacokinetics
Half-life: Osimertinib — 48 hours; Rabeprazole — 1-2 hours.
Chemical Properties
Molecular Formula: Osimertinib — C28H33N7O2; Rabeprazole — C18H21N3O3S.
Molecular Weight: Osimertinib — 499.6050 g/mol; Rabeprazole — 359.4440 g/mol.
Type: Osimertinib — Small molecule; Rabeprazole — Small molecule.